Literature DB >> 6604718

Quantitation of perfused myocardial mass using Tl-201 and emission computed tomography.

B L Holman, S C Moore, P M Shulkin, C M Kirsch, R J English, T C Hill.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6604718     DOI: 10.1097/00004424-198307000-00006

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  6 in total

Review 1.  An overview of radiotracers in nuclear cardiology.

Authors:  W Acampa; C Di Benedetto; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Tomographic and planar quantitation of perfusion defects on technetium 99m-labeled sestamibi scans: evaluation in patients treated with thrombolytic therapy for acute myocardial infarction.

Authors:  L A Mortelmans; F J Wackers; J L Nuyts; I A Scheys; T Brzostek; C W Schiepers; E E Lesaffre; P L Suetens; A M Verbruggen; F J Van de Werf
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

3.  Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity.

Authors:  T Benoit; D Vivegnis; J Foulon; P Rigo
Journal:  Eur J Nucl Med       Date:  1996-12

4.  Quantification of myocardial ischemia and infarction with single photon emission computed tomography.

Authors:  H M Hoffmeister; H Hanke; R Unterberg; W Voelker; W Kaiser; W Müller-Schauenburg; K R Karsch
Journal:  Eur J Nucl Med       Date:  1989

5.  The effect of heart rate and contractility on the measurement of left ventricular mass by 201Tl SPECT.

Authors:  J Machac; R Vaquer; H Levin; S F Horowitz
Journal:  Eur J Nucl Med       Date:  1987

6.  In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi).

Authors:  M K O'Connor; T Hammell; R J Gibbons
Journal:  Eur J Nucl Med       Date:  1990
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.